Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Net Income towards Common Stockholders: 2013-2022

Historic Net Income towards Common Stockholders for Cellectis (CLLS) over the last 10 years, with Dec 2022 value amounting to -$106.1 million.

  • Cellectis' Net Income towards Common Stockholders rose 38.59% to -$17.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$86.1 million, marking a year-over-year increase of 17.49%. This contributed to the annual value of -$106.1 million for FY2022, which is 7.06% up from last year.
  • Cellectis' Net Income towards Common Stockholders amounted to -$106.1 million in FY2022, which was up 7.06% from -$114.2 million recorded in FY2021.
  • In the past 5 years, Cellectis' Net Income towards Common Stockholders ranged from a high of -$78.7 million in FY2018 and a low of -$114.2 million during FY2021.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was -$106.1 million (2022), whereas its average is -$100.5 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 79,093.50% in 2018, then grew by 20.59% in 2020.
  • Over the past 5 years, Cellectis' Net Income towards Common Stockholders (Yearly) stood at -$78.7 million in 2018, then dropped by 29.73% to -$102.1 million in 2019, then increased by 20.59% to -$81.1 million in 2020, then tumbled by 40.86% to -$114.2 million in 2021, then rose by 7.06% to -$106.1 million in 2022.